{
    "2018-11-01": [
        [
            {
                "time": "",
                "original_text": "上海医药2018年三季报点评:研发费用投入加大,分销结构继续调整",
                "features": {
                    "keywords": [
                        "上海医药",
                        "三季报",
                        "研发费用",
                        "分销结构"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报:底部特征明显,关注绩优个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "底部特征",
                        "绩优个股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}